Trials
2 active
4 in total · 1 in the EU
Targets
—
None known yet
What this is
- How it works
- How it works isn't classified yet
- How it’s given
- “Participants will receive zibotentan/dapagliflozin in fixed-dose combination as per the arms they are randomized to”In the company’s words, NCT06087835 on ClinicalTrials.gov
- Tested for
- Chronic Kidney Disease With High Proteinuria (2 trials)
- Main trialPhase 3
- “This is a Phase III, randomised, multicentre, double-blinded study to evaluate efficacy, safety and tolerability of treatment with zibotentan/dapagliflozin and dapagliflozin alone in participants with chronic kidney disease (CKD) and high proteinuria”In the company’s words, NCT06087835 on ClinicalTrials.gov
Other drugs for Chronic Kidney Disease With High Proteinuria
- AvelumabEMD Serono Research & Development Institute, Inc. · Phase 3
- MT1013Shaanxi Micot Pharmaceutical Technology Co., Ltd. · Phase 3
- HSK39297Haisco Pharmaceutical Group Co., Ltd. · Phase 3
- BaxdrostatAstraZeneca · Phase 3
- BelzutifanMerck & Co. · Phase 3
- AbexinostatXynomic Pharmaceuticals, Inc. · Phase 3
Coming up1
- 18 Feb 2027Phase 3 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials4
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 3Active, not recruiting | 18 Feb 2027 | Study to Investigate Efficacy, Safety, and Tolerability of Zibotentan/Dapagliflozin Compared to Dapagliflozin in Participants With Chronic Kidney Disease and High Proteinuria (ZENITH High Proteinuria) | |
| Phase 2Active, not recruiting | 26 Sep 2026 | A Study to Investigate the Effects of Zibotentan/Dapagliflozin Combination Compared to Dapagliflozin Alone in Adult Participants With Chronic Kidney Disease and High Proteinuria | |
| Phase 1Completed | 22 Oct 2021 | Study to Collect Samples for MIST Analysis of Zibotentan and Bioavailability of Zibotentan and Dapagliflozin in Heatlhy Participants | |
| Phase 1Completed | 2 Apr 2026 | A Study to Investigate the Concentrations of Zibotentan and Dapagliflozin in Blood When Given With and Without Food |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026